|
|
|
41
|
30317
|
ADRENALINE|LIDOCAINE 0.001%|1% INJ (KWA)
|
ADRENALINE|LIDOCAINE
|
ADRENALINE|LIDOCAINE
|
30ML
|
B
|
7.4754
|
7.4754
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
7200
|
LOCAL ANESTHETICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
LOCAL ANESTHETICS
|
|
|
|
|
40
|
3032C
|
ADRENALINE | LIDOCAINE 0.001% | 2% INJ (FSB/ATB)
|
ADRENALINE|LIDOCAINE
|
ADRENALINE|LIDOCAINE
|
30ML
|
B
|
4.08
|
4.08
|
INJECTION
|
0
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
7200
|
LOCAL ANESTHETICS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
IV
|
0
|
LOCAL ANESTHETICS
|
2021-11-18
|
|
|
|
42
|
3051AB
|
OXYTOCIN 10U/ML INJ (LAF)
|
OXYTOCIN
|
OXYTOCIN
|
100X1ML
|
BQ
|
86.04
|
0.86
|
VIAL
|
0
|
VIAL
|
LAF
|
LABORATORIOS ALFA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
7600
|
OXYTOCICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
40
|
3051E
|
OXYTOCIN 10U/ML INJ (RTM/PHA)
|
OXYTOCIN
|
OXYTOCIN
|
10X1ML
|
BQ
|
9.68
|
0.97
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
7600
|
OXYTOCICS
|
2022-04-01
|
2022-05-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
40
|
3051E
|
OXYTOCIN 10U/ML INJ (RTM/PHA)
|
OXYTOCIN
|
OXYTOCIN
|
10X1ML
|
BQ
|
12.40
|
1.24
|
INJECTION
|
0
|
AMP
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
7600
|
OXYTOCICS
|
2022-06-01
|
2024-03-31
|
Price Change
|
IV
|
0
|
OXYTOCICS
|
2022-05-31
|
|
|
|
41
|
3051E
|
OXYTOCIN 10U/ML INJ (RTM) (BQ)
|
OXYTOCIN
|
OXYTOCIN
|
10X1ML
|
BQ
|
10.33
|
1.033
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
7600
|
OXYTOCICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
42
|
3051E
|
OXYTOCIN 10U/ML INJ (RTM)
|
OXYTOCIN
|
OXYTOCIN
|
10X1ML
|
BQ
|
10.33
|
1.03
|
AMPG
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
7600
|
OXYTOCICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
40
|
3051M
|
DURATOCIN 100MCG/ML INJ (FER/STO) CARBETOCIN
|
CARBETOCIN
|
DURATOCIN
|
5X1ML
|
BQ
|
259.25
|
51.85
|
INJECTION
|
0
|
AMP
|
FER
|
FERRING PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
|
7600
|
OXYTOCICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
41
|
3051M
|
DURATOCIN 100MCG/ML INJ (FER) CARBETOCIN (BQ)
|
CARBETOCIN
|
DURATOCIN
|
5X1ML
|
BQ
|
273.41
|
54.6818
|
AMP
|
50
|
BOX
|
FER
|
FERRING PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
|
7600
|
OXYTOCICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
42
|
3051M
|
DURATOCIN 100MCG/ML INJ (FER) CARBETOCIN
|
CARBETOCIN
|
DURATOCIN
|
5X1ML
|
BQ
|
306.46
|
61.29
|
AMPG
|
50
|
BOX
|
FER
|
FERRING PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
|
7600
|
OXYTOCICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
41
|
3051W
|
OXYTOCIN 10U/ML INJ (KWA) (BQ)
|
OXYTOCIN
|
OXYTOCIN
|
10X1ML
|
BQ
|
8.32
|
0.8318
|
AMP
|
0
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
7600
|
OXYTOCICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OXYTOCICS
|
|
|
|
|
40
|
30612
|
RHOPHYLAC 300MCG INJ (CSL/AHI) ANTI-D IMMUNOG
|
ANTI-D IMMUNOGLOBULIN
|
RHOPHYLAC
|
2ML AMP
|
BQ
|
108.73
|
108.73
|
INJECTION
|
0
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
30612
|
RHOPHYLAC 300MCG INJ (CSL) ANTI-D IMMUNO
|
ANTI-D IMMUNOGLOBULIN
|
RHOPHYLAC
|
2ML AMP
|
BQ
|
122.32
|
122.3246
|
AMP
|
2
|
AMP
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
40
|
3061B
|
HYPERRHOD 300MCG INJ (GRB/COL) ANTI D IMMUNOG
|
ANTI-D IMMUNOGLOBULIN
|
HYPERRHOD
|
300MCG VL
|
BQ
|
250.09
|
250.09
|
INJECTION
|
0
|
VIAL
|
GRB
|
GRIFOLS BIOLOGICALS INC
|
COL
|
COLLINS LTD
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
42
|
3061E
|
RHOPHYLAC 150MCG/ML PREFIL SYRN (CSL) IMMUNOGLOBULIN ANTI-D
|
IMMUNOGLOBULIN ANTI-D
|
RHOPHYLAC
|
1X2ML PFS
|
BQ
|
122.32
|
122.32
|
PFS
|
0
|
PFS
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
2028-03-31
|
|
IV/IM
|
0
|
SERUMS
|
2025-11-10
|
|
|
|
40
|
3081Y
|
IMMUNOREL 5% INJ (RLS/AHI) IMMUNOGLOBULIN
|
IMMUNOGLOBULIN HUMAN
|
IMMUNOREL
|
100ML
|
BQ
|
657.29
|
657.29
|
INJECTION
|
0
|
BOTT
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
3081Y
|
IMMUNOREL 5% INJ (RLS) IMMUNOGLOBUL (BQ)
|
IMMUNOGLOBULIN HUMAN
|
IMMUNOREL
|
100ML
|
BQ
|
807.34
|
807.3422
|
BOTT
|
0
|
BOTT
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
42
|
3081Y
|
IMMUNOREL 5% INJ (RLS) IMMUNOGLOBUL
|
IMMUNOGLOBULIN HUMAN
|
IMMUNOREL
|
100ML
|
BQ
|
807.34
|
807.34
|
BOTT
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
40
|
30827
|
PRIVIGEN 10% INJ (CSL/AHI) IMMUNOGLOBULIN
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
50ML
|
BQ
|
951.41
|
951.41
|
INJECTION
|
0
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
30827
|
PRIVIGEN 10% INJ (CSL) IMMUNOGLOBULIN (BQ)
|
IMMUNOGLOBULIN HUMAN
|
PRIVIGEN
|
50ML
|
BQ
|
883.46
|
883.4553
|
BOTT
|
50
|
BOTT
|
CSL
|
CSL BEHRING AG
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
